Skip to content
Plasma Portal UK

Zimbabwe Declines ‘Unbalanced’ US Healthcare Assistance Agreement Over Information Apprehensions

Health funding illustration
The proposed US funding was aimed at initiatives for treating and preventing HIV/Aids, tuberculosis, and malaria.

The nation of Zimbabwe has rejected a major American health deal worth $367m (272 million pounds) spanning five years over the United States' insistence on confidential information.

The decision came to light following a internal memorandum dated December was disclosed, which showed Head of State Emmerson Mnangagwa felt the deal was "skewed".

A government spokesman has since explained that the US was seeking biological samples for scientific study and commercial gain while was unwilling to guarantee the resulting advantages from future treatments.

"We are forced to start the challenging and unfortunate process of ending our support in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.

Her embassy said the US had donated more than $1.9bn as health assistance to Zimbabwe over the last two decades.

A physicians' group in Zimbabwe has called for continued dialogue to find a deal acceptable to all parties so the country's critical HIV programme can continue.

Broader Implications

This rejection comes after a similar case in neighbouring Kenya, where a court suspended a related deal with the US after concerns were raised about the security of Kenyans' health data.

Since returning to the presidency recently, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.

The agency had administered assistance for the American government, but Trump stated its spending was "wasteful" and his administration was pursuing government-to-government agreements to enhance transparency and accountability.

According to reports, Sixteen nations in Africa have so far signed these new health pacts, constituting more than $18.3bn in new funding.

Details of the Declined Deal

The money for Zimbabwe would have supported "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"We believe this collaboration might have yielded significant benefits for the people of Zimbabwe, especially the 1.2 million men, women and children currently on antiretroviral therapy via American-funded initiatives," the Ambassador commented.

However, government spokesperson Nick Mangwana argued the arrangement was "asymmetrical".

"Our nation was requested to surrender its genetic material and health information indefinitely, with no corresponding guarantee of benefiting from any medical innovations – such as new medicines or tests – that might be developed from that provided information," his statement read.

"Effectively, our nation would supply the raw materials for scientific discovery without any certainty that the final treatments would be available to our citizens should a future health crisis arise."

National Interest and International Frameworks

Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral deals were undermining frameworks already set up via the global organization.

The spokesperson cited its Pathogen Access and Benefit Sharing scheme created to deal with potential pandemics.

"This mechanism is designed to guarantee that when a country contributes its information, the benefits – such as medicines and cures – are shared equitably, not commercialised exclusively by those with the resources to create them."

The government's concerns over the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.

"We encourage continued dialogue with our American counterparts on how subsequent co-operation could be arranged in a way that honours the independence and interests of each country."

Health Experts Response

The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the official position, but urged that talks need to persist considering a large portion of the nation's Aids initiatives relied on foreign aid.

"Where technical issues arise, such as those relating to information security or implementation frameworks, these can often be resolved via technical clarification and negotiated safeguards," the group added.

The halted deal underscores the continuing tensions between accepting vital foreign assistance and safeguarding local interests in an increasingly data-driven world.

KC
By

Kathleen Cooper

A plasma physicist with over 15 years of research experience in fusion energy and materials science, passionate about making complex science accessible.

Plasma Portal UK

Type to search articles.